FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 6.4M | 29.6M | 147.8M | 140.7M | 235.3M | 176.3M |
| Gross Profit | 5.9M | 14.1M | 128.9M | 120.5M | 222.4M | 167.4M |
| Profitability | ||||||
| Operating Income | -45.3M | -131.0M | -269.2M | -301.0M | -288.5M | -191.9M |
| EBITDA | -41.7M | -123.0M | -248.8M | -282.8M | -273.7M | -164.3M |
| Net Income | 183.5M | -47.6M | -284.2M | -293.7M | -290.0M | -189.3M |
| Per Share Data | ||||||
| EPS (diluted) | $45.37 | $-12.00 | $-2.92 | $-3.14 | $-3.14 | $-2.11 |
| Shares Outstanding (dil.) | 4M | 4M | 97M | 94M | 92M | 90M |
FibroGen, Inc. Income Statement — FAQ
FibroGen, Inc. (KYNB) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's income statement history?
The chart and table above show FibroGen, Inc.'s income statement by year and by quarter, including the growth rate.